Cargando…
Screening and Identification of Novel Potential Biomarkers for Breast Cancer Brain Metastases
Brain metastases represent a major cause of mortality among patients with breast cancer, and few effective targeted treatment options are currently available. Development of new biomarkers and therapeutic targets for breast cancer brain metastases (BCBM) is therefore urgently needed. In this study,...
Autores principales: | Wang, Lulu, Zeng, Dan, Wang, Qi, Liu, Li, Lu, Tao, Gao, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792448/ https://www.ncbi.nlm.nih.gov/pubmed/35096583 http://dx.doi.org/10.3389/fonc.2021.784096 |
Ejemplares similares
-
The Role of the Immune Response in Brain Metastases: Novel Imaging Biomarkers for Immunotherapy
por: Zakaria, Rasheed, et al.
Publicado: (2021) -
Potential biomarkers for the early detection of bone metastases
por: Hao, Yang, et al.
Publicado: (2023) -
Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases
por: Contreras-Zárate, María J., et al.
Publicado: (2017) -
Identification of Candidate Biomarkers and Prognostic Analysis in Colorectal Cancer Liver Metastases
por: Zhang, Tianhao, et al.
Publicado: (2021) -
Pyrotinib-based treatments in HER2-positive breast cancer patients with brain metastases
por: Ma, Xiaoping, et al.
Publicado: (2022)